POLR3A and cancer: This observation suggests that mutations occurring in the POLR3A locus during tumor growth lead to an immune response directed against both cancer cells carrying the mutated POLR3A locus as well as to normal cells expressing only wild-type POLR3A, and thus to an autoimmune response.